Bahrain has approved the use of synoform vaccine

This time, Bahrain approved the use of a vaccine made by Corona China’s National Pharmaceutical Group and Sinofarm.

On Sunday, the country’s health regulatory authority approved the use of the Chinese vaccine. The country has decided to verify and monitor the results of the third and final trial.

After the trial, it was found that this vaccine has 86% effectiveness in preventing coronary infection. It is also effective in treating severe corona patients.

A total of 42,299 people took part in the third trial of the synoform vaccine, which started last August. In November, the vaccine was approved on an emergency basis for health workers treating Corona patients.